The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2019 | Updates in amyloidosis: ISA 2020
Joan Bladé, MD, PhD, of Hospital Clinic, Barcelona, Spain, briefly describes new agents used in the treatment of relapsed amyloidosis, including daratumumab in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd). Additionally, Dr Bladé discusses the upcoming International Symposium on Amyloidosis (ISA) in March 2020, to be held in Tarragona, Spain, of which Dr Bladé will be President. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.
